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Abstract
 
Engagement of the Fc
 
 
 
 receptor I (Fc
 
 
 
RI) on mast cells and basophils initiates signaling path-
ways leading to degranulation. Early activation events include tyrosine phosphorylation of two
transmembrane adaptor proteins, linker for activation of T cells (LAT) and non–T cell activa-
tion linker (NTAL; also called LAB; a product of 
 
Wbscr5
 
 gene). Previous studies showed that
the secretory response was partially inhibited in bone marrow–derived mast cells (BMMCs)
from LAT-deficient mice. To clarify the role of NTAL in mast cell degranulation, we com-
pared Fc
 
 
 
RI-mediated signaling events in BMMCs from NTAL-deficient and wild-type mice.
Although NTAL is structurally similar to LAT, antigen-mediated degranulation responses were
unexpectedly increased in NTAL-deficient mast cells. The earliest event affected was enhanced
tyrosine phosphorylation of LAT in antigen-activated cells. This was accompanied by en-
hanced tyrosine phosphorylation and enzymatic activity of phospholipase C 
 
 
 
1 and phospholi-
pase C
 
  
 
2, resulting in elevated levels of inositol 1,4,5-trisphosphate and free intracellular Ca
 
2
 
 
 
.
NTAL-deficient BMMCs also exhibited an enhanced activity of phosphatidylinositol 3-OH
kinase and Src homology 2 domain–containing protein tyrosine phosphatase-2. Although both
LAT and NTAL are considered to be localized in membrane rafts, immunogold electron mi-
croscopy on isolated membrane sheets demonstrated their independent clustering. The com-
bined data show that NTAL is functionally and topographically different from LAT.
Key words: mast cell • signal transduction • Fc
 
 
 
 receptor • calcium mobilization • 
adapter molecules
s ˇ S ˇ S ˇ
r ˇ s ˇ
 
Introduction
 
Mast cells play a pivotal role in initiating acute inflamma-
tory and immediate allergic reactions. The binding of mul-
tivalent antigen (Ag) to receptor-bound IgE and subse-
quent aggregation of the Fc
 
 
 
 receptor I (Fc
 
 
 
RI) provide
the trigger for mast cell activation, resulting in a release of
histamine, serotonin, and other preformed inflammatory
mediators, as well as de novo synthesis and subsequent se-
cretion of arachidonic acid metabolites and a variety of in-
flammatory cytokines. These signal transduction pathways
are initiated by the engagement of protein tyrosine kinases
of the Src and Syk families. Src family kinase Lyn phosphory-
lates immunoreceptor tyrosine-based activation motifs present
on Fc
 
 
 
RI 
 
 
 
 and 
 
 
 
 subunits. This leads to a recruitment and
subsequent activation of Syk kinase, which phosphorylates
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Abbreviations used in this paper:
 
 Ag, antigen; BMMC, BM-derived mast
cell; BSS, buffered saline solution; [Ca
 
2
 
 
 
]
 
i
 
, concentration of free intracellular
calcium; ES, embryonic stem; Fc
 
 
 
RI, Fc
 
 
 
 receptor I; HRP, horseradish
peroxidase; IP3, inositol 1,4,5-trisphosphate; LAT, linker for activation of
T cells; MAP, mitogen-activated protein; NTAL, non–T cell activation
linker; PI, phosphatidylinositol; PI3K, PI 3-OH kinase; PLC, phospholipase
C; PS, phosphatidylserine; SCF, stem cell factor; SH, Src homology. 
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several downstream signaling molecules, including the
linker for activation of T cells (LAT). Phosphorylated LAT
recruits a number of signaling molecules containing Src ho-
mology (SH)2 domains, such as adaptor protein Grb2 and
phospholipase C (PLC)
 
 
 
1 and PLC
 
 
 
2. An important inter-
mediate is phosphatidylinositol (PI) 3-OH kinase (PI3K),
which catalyzes the synthesis of PI 3,4-bisphosphate and PI
3,4,5-trisphosphate. These phospholipids contribute to re-
cruitment to the plasma membrane of Akt and PLC
 
 
 
 and
other molecules containing pleckstrin homology domains.
PLC
 
 
 
 catalyzes the cleavage of the lipid substrate PI 4,5-
bisphosphate into diacylglycerol, an activator of protein ki-
nase C, and inositol 1,4,5-trisphosphate (IP3), a ligand for
the IP3 receptor Ca
 
2
 
 
 
 channel in the ER membrane that
initiates a rise in cytoplasmic Ca
 
2
 
 
 
 levels. This is followed
by a more sustained influx of extracellular calcium through
Ca
 
2
 
 
 
 channels in the plasma membrane. Many of these
events rely on formation of multimolecular signaling com-
plexes that propagate the activation signal from aggregated
Fc
 
 
 
RI (1).
Recently, we have found that mast cells express a LAT-
related transmembrane adaptor protein, the non–T cell ac-
tivation linker (NTAL) (2). NTAL, also called LAB (3),
was also found to be expressed in other cell types, such as B
lymphocytes, NK cells, and monocytes but not in T lym-
phocytes. NTAL resembles LAT in general organization,
consisting of a short extracellular domain, a single hydro-
phobic transmembrane domain, and a cytoplasmic tail with
multiple tyrosine phosphorylation sites and two potential
palmitoylation sites. The two acylation sites are likely re-
sponsible for partitioning of NTAL into detergent-resistant
membrane microdomains, also called lipid rafts (4). NTAL
is rapidly tyrosine phosphorylated upon engagement of
Fc
 
 
 
RI, Fc
 
 
 
RI, or B cell receptor (2, 3). Functional similar-
ity between LAT and NTAL was suggested by experiments
in which ectopically expressed NTAL could partially re-
store some aspects of T cell receptor signaling in LAT-defi-
cient cells (2). Furthermore, NTAL expressed in T cells
could in part rescue the T cell development in LAT
 
 
 
/
 
 
 
mice (3, 5). An important functional role of NTAL in im-
munoreceptor signaling was suggested by experiments in
which a diminution of NTAL expression by silencing
RNA oligonucleotides resulted in a reduction of B cell re-
ceptor–mediated activation of mitogen-activated protein
(MAP) kinase in A20 cell line (3), as well as in a reduced
degranulation in Fc
 
 
 
RI-activated human mast cells (6).
Using a genetic approach, Saitoh et al. showed that mast
cell effector functions were impaired but not completely
inhibited in BM-derived mast cells (BMMCs) from LAT-
deficient mice (7). Accordingly, low levels of PLC
 
 
 
 activa-
tion and calcium response were detected in LAT-deficient
BMMCs, suggesting the existence of alternative pathways.
One alternative pathway independent of Lyn kinase and
LAT phosphorylation but dependent on Fyn kinase and
Gab2 adaptor has been described recently (8). In this study,
we analyzed the signaling events in BMMCs from NTAL-
deficient mice and compared them with those observed in
WT mice or mice deficient in both NTAL and LAT link-
ers. Furthermore, we analyzed the respective topography of
NTAL and LAT on membrane sheets isolated from nonac-
tivated and activated mast cells.
 
Materials and Methods
 
Antibodies and Reagents.
 
The following mAbs have been used:
anti-Syk (9), anti-LAT (10), anti-Fc
 
 
 
RI 
 
 
 
 subunit (JRK) (11),
anti-NTAL (NAP-07) (2), TNP-specific IgE mAb (IGEL b4 1)
(12), and DNP-specific IgE mAb (13). Polyclonal antibodies spe-
cific for Syk, LAT, NTAL, and IgE have been prepared by com-
mon procedures after immunizing rabbits with the corresponding
proteins or their fragments (14). Polyclonal antibodies specific for
PLC
 
 
 
1, PLC
 
 
 
2, ERK 1, phospho-ERK (specific for phosphory-
lated Tyr 204), Grb2, SH2-containing protein tyrosine phos-
phatase (SHP)-2, and horseradish peroxidase (HRP)–conjugated
donkey anti–goat IgG, goat anti–mouse IgG, and goat anti–rabbit
IgG were obtained from Santa Cruz Biotechnology, Inc. Rabbit
anti-PI3K p85 subunit antibody (a mixture of equal amounts of
antisera against the intact p85 subunit and the N-SH2 region of
PI3K) was obtained from Upstate Biotechnology. Phospho-Tyr–
specific mAb (PY-20) conjugated to HRP was purchased from
Transduction Laboratories. Biotinylated rat anti–mouse c-kit,
FITC-labeled rat anti–mouse IgE antibody, and phycoerythrin-
labeled streptavidin were from BD Biosciences. Goat anti–mouse
IgG and anti–rabbit IgG conjugated to colloidal gold particles of
10- and 5-nm were obtained from Amersham Biosciences. Fura-
2-AM and 
 
45
 
Ca (37 MBq; specific activity 566 MBq/mg Ca
 
2
 
 
 
)
were purchased from Molecular Probes and MP Biomedicals,
Inc., respectively. All other chemicals were obtained from Sigma-
Aldrich.
 
Vector Construction.
 
The targeting construct used for disrup-
tion of the 
 
Ntal
 
 gene is shown in Fig. 1 b. It should be noted that
the official name of the gene is 
 
Wbscr5
 
. The 5
 
 
 
 homologous se-
quences correspond to a gene segment encompassing nucleotide
positions 79680–81447 (sequence data available from GenBank/
EMBL/DDBJ under accession no. AF139987). The 3
 
 
 
 homolo-
gous sequences correspond to a gene segment encompassing nu-
cleotide positions 87023–91726 (sequence data available from
GenBank/EMBL/DDBJ under accession no. AF139987). In the
engineered vector, the sequence containing exons 2–9 of the 
 
Ntal
 
gene and coding for amino acids 1–121 of the NTAL protein was
replaced by a lox P–flanked neomycin-resistance gene (neo
 
r
 
). Fi-
nally, the targeting construct was abutted to a thymidine kinase
expression cassette and linearized.
 
Isolation of Recombinant Embryonic Stem Cell Clones and Produc-
tion of Mutant Mice.
 
After electroporation of CK35 129/CV em-
bryonic stem (ES) cells (15) and selection in G418 and gancyclovir,
colonies were screened for homologous recombination by South-
ern blot analysis. The 5
 
 
 
 single copy probe corresponded to a 400-bp
EcoRI–XbaI fragment. When tested on EcoRI-digested DNA, it
hybridized either to a 8-kb WT fragment or to a 2.5-kb re-
combinant fragment. The presence of an appropriate homolo-
gous recombination event at the 3
 
 
 
 side was assessed using a 1051-
bp XbaI–EcoRI fragment. When tested on HindIII-digested DNA,
it hybridized either to a 9.5-kb WT fragment or to a 6.7-kb recom-
binant fragment. A neo probe was also used to ensure that adventi-
tious nonhomologous recombination events had not occurred in
the selected clones. Among the recombinant ES cell clones, one
was found capable of germline transmission. The resulting mutant
mouse line was first bred to Deleter mice (16) to eliminate the lox 
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P–flanked neomycin cassette and intercrossed to produce homozy-
gous mutant mice. Screening of mice for the presence of the 
 
Ntal
 
-
null mutation was performed by PCR using the following oligo-
nucleotides: a: 5
 
 
 
-CTACGGAGCTGAGTGTTCTCA-3
 
 
 
, b:
5
 
 
 
-GAACGGCTAGAACTACACAGAG-3
 
 
 
, c: 5
 
 
 
-GAGAGGA-
GGATAAAGTGGACCTC-3
 
 
 
. WT 
 
Ntal
 
 allele is visualized as a
383-bp fragment using the a-b pair of oligonucleotides, whereas the
intended mutation is visualized as a 450-bp fragment using the a-c
pair of oligonucleotides. Production of LAT
 
 
 
/
 
 
 
 mice has been de-
scribed (17). NTAL
 
 
 
/
 
 
 
 and LAT
 
 
 
/
 
 
 
 mice were bread to generate
the NTAL
 
 
 
/
 
 
 
/LAT
 
 
 
/
 
 
 
 strain. All mice were maintained and used
in accordance with the Institute of Molecular Genetics guidelines.
 
Cells.
 
BMMCs were isolated from the femurs and tibias of
the 6–10-wk-old mice. The cells were incubated for 4–8 wk in
suspension cultures in freshly prepared culture media (RPMI-
1640 supplemented with 20 mM Hepes, pH 7.5, 100 U/ml pen-
icillin, 100 
 
 
 
g/ml streptomycin, 100 
 
 
 
M MEM nonessential
amino acids, 1 mM sodium pyruvate, 17% FCS, 41 
 
 
 
M 2-ME)
supplemented with IL-3 (20 ng/ml; PeproTech EC) and stem
cell factor (SCF; 40 ng/ml; PeproTech EC). No discernible dif-
ferences in growth properties and morphology were detected
among BMMCs derived from NTAL
 
 
 
/
 
 
 
, NTAL
 
 
 
/
 
 
 
, NTAL
 
 
 
/
 
 
 
,
LAT
 
 
 
/
 
 
 
, and NTAL
 
 
 
/
 
 
 
/LAT
 
 
 
/
 
 
 
 mice.
 
 
 
Before activation, BMMCs
were cultured for 16 h in culture medium without SCF, followed
by incubation for 3–4 h in SCF- and IL-3–free medium supple-
mented with anti-TNP IgE (1 
 
 
 
g/ml). The cells were then washed
in buffered saline solution (BSS) containing 20 mM Hepes, pH
7.4, 135 mM NaCl, 5 mM KCl, 1.8 mM CaCl
 
2
 
, 5.6 mM glu-
cose, 1 mM MgCl
 
2
 
, and 0.1% BSA (BSS-BSA), and challenged
with various concentrations of TNP-BSA.
 
Flow Cytometry Analyses of Fc
 
 
 
RI and Phosphatidylserine Expres-
sion.
 
Flow cytometry analyses of Fc
 
 
 
RI in unfractioned freshly
isolated peritoneal mast cells (c-kit positive) and BMMCs were
performed as described (18) except that in the first incubation step
the cells were exposed to TNP-specific IgE. To determine exter-
nalization of phosphatidylserine
 
 
 
(PS), cells were exposed to FITC-
labeled annexin V (Alexis) and then analyzed using FACSCalibur
and CellQuest software (Beckton Dickinson) as described (19).
 
Passive Systemic Anaphylaxis and Degranulation.
 
Mice were sen-
sitized  by i.v. tail vein injection of TNP-specific IgE (3 
 
 
 
g/
mouse) and 24 h later challenged by i.v. tail vein injection with
TNP-BSA (500 
 
 
 
g/mouse) or vehicle (PBS). After 1.5 min, the
animals were killed, blood samples were obtained by cervical
puncture, and serum was isolated. Serum histamine concentra-
tions were determined according to the manufacturer’s protocol
using a histamine radioimmunoassay kit (Immunotech). Statistical
significance of differences among particular groups was deter-
mined using Student’s 
 
t
 
-test. The degree of degranulation was
determined by measuring the release of 
 
 
 
-glucuronidase from
anti-TNP IgE-sensitized and TNP-BSA–activated cells as de-
scribed (20).
 
Immunoprecipitation and Immunoblotting.
 
Activated and control
cells were lysed in ice cold lysis buffer (50 mM Tris-HCl, pH 7.4,
150 mM NaCl, 2 mM EDTA, 10 mM 
 
 
 
-glycerophosphate, 1
mM Na
 
3
 
VO
 
4
 
, 1 mM PMSF, 1 
 
 g/ml aprotinin, 1  g/ml leu-
peptin) supplemented with 1% NP-40 and 1% n-dodecyl  -d-
maltoside (for LAT, and NTAL immunoprecipitation or for
ERK immunoblotting) or 0.2% Triton X-100 (for Fc RI immu-
noprecipitation). In some experiments, association of the proteins
under study with large macromolecular complexes was analyzed
Figure 1. Generation and identification of Ntal-
deficient mice. (a–d) Schematics of the Ntal knock-out
strategy. (a) Partial restriction map of the WT Ntal
gene. Exons are shown as filled boxes. The restriction
sites are EcoRI (E) and Hind III (H). The exons con-
taining the initiation (start) and the stop codon are
specified. (b) Targeting vector used for the deletion of
exons 2–9. Shaded or open boxes correspond to the
thymidine kinase expression cassette (TK) and to the
lox P–flanked neor cassette, respectively. Lox P sites are
shown as triangles. (c) Structure of the targeted allele
after homologous recombination. (d) Final structure of
the targeted allele after removal of the neor gene via
cre-mediated recombination. The 5  and 3  single
copy probes used to verify 5  and 3  targeting events
are indicated, and the position of the PCR primers
used to genotype the resulting mice are indicated by
arrows. (e) Southern blot analysis of three recombinant
ES cell clones including the one that gave germline
transmission (clone 1). DNA was digested as specified
and hybridized with the 5  or 3  single copy probe.
(f) PCR genotyping of Ntal-deficient and -proficient
littermates using primers indicated in panel d.NTAL in Mast Cell Signaling 1004
in cells permeabilized with 0.1% saponin in PBS, thus releasing
free cytoplasmic components, and the cellular ghosts were ex-
tracted for 15 min on ice in a lysis buffer supplemented with 1%
Triton X-100 (21). Proteins in postnuclear supernatants were im-
munoprecipitated with the corresponding antibodies bound to
UltraLink-immobilized protein A (Pierce Chemical Co.) and an-
alyzed by immunoblotting as described (9). Some proteins were
analyzed by direct immunoblotting of SDS-PAGE–fractionated
cell lysates. Immunoblots were quantified by Luminescent Image
Analyzer LAS 3000 (Fuji Photo Film Co.).
Sucrose Gradients. Cells were solubilized in lysis buffer con-
taining 1% Brij 96 and fractionated by sucrose density gradient
ultracentrifugation as described (20).
Measurements of Intracellular Ca2  Concentrations and 45Ca Up-
take. Concentrations of free intracellular calcium [Ca2 ]i were
determined using Fura-2-AM as a reporter. BMMCs were sensi-
tized with anti-TNP IgE (1  g/ml) at 37 C in culture medium
supplemented with 2% FCS but devoid of SCF and IL-3. After
3–4 h, the cells were washed and resuspended at a concentration
5   106/ml in BSS-BSA supplemented with Fura-2-AM and
probenecid at a final concentration of 1  g/ml and 2.5 mM, re-
spectively. After 30 min, the cells were washed in BSS-BSA sup-
plemented with probenecid and immediately before measure-
ment briefly centrifuged and resuspended in BSS-BSA. Calcium
mobilization was determined using luminescence spectrometer
LS-50B (PerkinElmer). Uptake of extracellular calcium was de-
termined as before (22) except that the radioactivity was mea-
sured in 10 ml scintillation liquid (EcoLite; ICN Biomedicals) in
QuantaSmart TM counter.
Immune Complex PI3K, PLC  and Syk Kinase Assays, and IP3
Determination. PI3K and PLC  activities and IP3 concentrations
were determined as described previously (21). Syk kinase activity
was determined by in vitro kinase assay (9).
In-gel Phosphatase Assay. SHP-2 immunoprecipitates were pre-
pared and analyzed by in-gel phosphatase assay as described (23).
Electron Microscopy. Cells were left overnight to settle on 15-mm
round-glass coverslips in the presence or absence of anti-DNP
IgE (1  g/ml). IgE-sensitized cells were activated by DNP-BSA
(1  g/ml), and membrane sheets were obtained and processed as
described (24). Fc RI, NTAL, and LAT were labeled by sequen-
tial incubation with the corresponding primary antibodies fol-
lowed by gold-conjugated secondary reagents diluted 1:20 from
commercial stocks. Samples were postfixed in 2% glutaraldehyde
in PBS, washed in PBS, and then stained with 1% OsO4 in 0.1 M
cacodylate buffer, 1% tannic acid, and 1% uranyl acetate. Samples
were examined using a Hitachi 600 transmission electron micro-
scope. Gold particles distribution was analyzed using software de-
veloped at the University of New Mexico (25). Clusters of parti-
cles of the same type were analyzed using the Hopkins and
Ripley’s statistics (25). In each of two independent experiments,
 30  m2 of plasma membranes from activated and resting cells
were analyzed.
Results
Enhanced Degranulation in NTAL /  Mast Cells. To ex-
plore the role of NTAL in mast cell physiology, we gener-
ated knock-out mice with a lox P sequence that replaced a
central segment of the Ntal gene containing exons 2–9 (Fig.
1). Mice homozygous for this mutation, Ntal / , were born
at the expected Mendelian frequencies and were deprived
of detectable NTAL protein (see next paragraph). First, we
analyzed the effect of NTAL on passive anaphylactic reac-
tion in vivo. In controls, the basal level of serum histamine
was identical in WT, NTAL / , and NTAL /  mice (Fig.
2 A). After challenge with Ag, the serum histamine levels
were enhanced in all mice, although the levels were signifi-
cantly higher in NTAL /  mice. The observed increase in
serum histamine was not attributable to elevated numbers of
mast cells in NTAL /  mice, as inferred from similar num-
bers of mast cells in peritoneal lavage of WT, NTAL / ,
and NTAL /  mice (2.5%   1.1%, mean   SD, n   9).
Furthermore, peritoneal mast cells (c-kit positive) from
NTAL /  and WT mice did not differ in the amount of
surface Fc RI as determined by flow cytometry (not de-
picted). These data suggested that the observed increase in
serum histamine levels in NTAL /  cells could reflect nega-
tive regulation of mast cell signaling by NTAL.
To investigate the underlying mechanism responsible for
the enhanced degranulation response in NTAL /  mice,
BMMCs from WT, NTAL / , or NTAL /  mice were
Figure 2. Enhanced passive systemic anaphylaxis in NTAL / , and
Fc RI and NTAL expression in BMMCs. (A) WT, NTAL / , and
NTAL /  mice were sensitized with TNP-specific IgE, challenged with
TNP-BSA ( ) or with PBS alone ( ), and the serum histamine levels
were determined. Numbers above the mean bars indicate the numbers of
mice in each group. The asterisk indicates a significant increase (P   0.01) of
histamine levels in NTAL /  mice compared with WT mice. (B) BMMCs
from WT, NTAL / , and NTAL /  mice were stained for surface
Fc RI by sequential exposure to anti-TNP IgE (1  g/ml, thick line) or
PBS alone (thin line) followed by anti–mouse IgG–FITC conjugate. The
samples were analyzed by flow cytometry. (C) NTAL expression levels in
lysates from BMMCs were determined by immunoblotting (IB) using
anti-NTAL mAb followed by anti–mouse IgG–HRP conjugate. As a
control for protein loading the membrane was also developed with rabbit
anti-LAT followed by anti–rabbit IgG–HRP conjugate.Volná et al. 1005
obtained by growing BM cells for 4–8 wk in the presence
of IL-3 and SCF. The cells expressed comparable amount
of Fc RI (Fig. 2 B) and LAT (Fig. 2 C) and the expected
amount of NTAL (Fig. 2 C). The cells were sensitized with
TNP-specific IgE and activated with various doses of Ag.
Data presented in Fig. 3 A indicate that Fc RI-mediated
degranulation was significantly increased in NTAL /  cells
compared with NTAL /  cells and WT cells, although the
total amount of  -glucuronidase present in the cells was
similar (not depicted). The most dramatic difference be-
tween WT and NTAL /  cells was observed at suboptimal
concentration of Ag (10 ng/ml). Under these conditions,
the NTAL /  cells released 40   2% of the total  -glu-
curonidase (mean   SD, n   12) compared with a maxi-
mum of 22   2% (n   12) in WT cells. These data were
confirmed in four independent BMMC isolates in each
group. Even at optimal (100 ng/ml) and supraoptimal (500
and 1,000 ng/ml) doses of Ag, the response in NTAL / 
BMMCs was significantly higher. When the cells were
stimulated with ionophore A23187, the differences be-
tween WT and NTAL /  cells disappeared (not depicted),
suggesting that NTAL affects early receptor-specific activa-
tion events which precede the calcium response.
An important feature of the degranulation process in mast
cells is PS externalization (19). In nonstimulated cells, PS is
found almost exclusively in the inner leaflet of the plasma
membrane. Fc RI-dependent degranulation leads to an ex-
posure of PS on the plasma membrane, detectable by bind-
ing of FITC-labeled annexin V to intact cells. Cytofluoro-
metric analyses showed that the number of annexin V
binding sites increased in WT cells with a maximum
reached at 100 ng/ml (Fig. 3 C). Activated NTAL /  cells
exhibited higher PS externalization than activated WT cells,
and again the most dramatic difference was observed at a
suboptimal dose of Ag (10 ng/ml). As expected (19), no PS
externalization in WT or NTAL /  cells was observed in
the absence of extracellular Ca2  (not depicted).
Tyrosine Phosphorylation of LAT Is Enhanced in NTAL / 
BMMCs. Next we assessed the tyrosine phosphorylation
of several proteins known to be involved in the initial stages
of Fc RI signaling. When total lysates from Ag-activated
cells were analyzed by immunoblotting with PY-20 mAb,
the most significant difference between WT and NTAL / 
cells was the absence in NTAL /  cells of a 30-kD phos-
phorylated protein corresponding in molecular weight to
NTAL (Fig. 3 D). Furthermore, NTAL /  cells exhibited
an increased tyrosine phosphorylation of a 38-kD protein,
corresponding to LAT (see end of this paragraph). If the IgE
receptor was immunoprecipitated from control and Ag-
activated cells, increased tyrosine phosphorylation of Fc RI
  and   subunits was observed in both WT and NTAL / 
cells after cell triggering, and no significant difference in the
extent and/or dynamics of tyrosine phosphorylation was
observed between these two groups (Fig. 4 A). Neither did
the Syk kinase immunoprecipitated from the whole cell ly-
sate exhibit any significant differences in amount, tyro-
sine phosphorylation, and kinase activity between WT and
NTAL /  cells (not depicted). However, when Syk was im-
munoprecipitated from cells first permeabilized with sapo-
nin in order to release free cytoplasmic components and
then solubilized with Triton X-100, increased amounts of
Syk and its phosphorylated form were precipitated from ac-
tivated NTAL /  cells relative to WT cells. This difference,
which apparently reflects enhanced association of Syk with
as yet unidentified plasma membrane component(s), was
more pronounced at later stages (5 min) after Fc RI trigger-
ing (Fig. 4 B). The most dramatic difference observed in
Figure 3. Enhanced degranulation, PS externalization, and tyrosine
phosphorylation in NTAL /  cells. BMMCs were sensitized with anti-
TNP IgE (1  g/ml) and then stimulated with Ag (TNP-BSA). (A and B)
 -Glucuronidase released into supernatant from cells stimulated for 30 min
with various concentrations of Ag. Data represent mean   SD (n   12 for
WT and NTAL /  cells; n   4 for NTAL /  cells; n   6 for LAT / 
and NTAL / /LAT /  cells). (C) Externalization of PS in WT and
NTAL /  BMMCs stimulated for 30 min with various concentrations of
Ag was determined by flow cytometry after surface staining of the cells
with FITC-labeled annexin V. Data were normalized to maximal values
in each assay and represent means   SD (n   3). (D) Cells were activated
with 100 ng/ml TNP-BSA for the indicated time intervals, solubilized in
1% NP-40 and 1% n-dodecyl- -d-maltoside, and the postnuclear super-
natants were size fractionated by SDS-PAGE. The extent of tyrosine
phosphorylation was determined by immunoblotting with PY-20–HRP
conjugate. Positions of molecular weight standards, LAT and NTAL, are
indicated on the left and right, respectively. A typical experiment from
three performed is shown.NTAL in Mast Cell Signaling 1006
NTAL /  cells was an increased tyrosine phosphorylation
of LAT at all time intervals analyzed (0.5–25 min; Fig. 4 C).
It should be noted, however, that we were unable to coim-
munoprecipitate Syk with LAT from either activated WT
or NTAL /  cells.
Next we examined whether NTAL is involved in
Fc RI-mediated Ras–MAP kinase signaling pathway. Ac-
tivation of MAP kinases was detected in total cellular ly-
sates by immunoblotting with anti–phospho-ERK. Data in
Fig. 4 D show that Fc RI-mediated tyrosine phosphoryla-
tion of the ERK was comparable in WT and NTAL / 
cell at early time intervals (0.5 and 5 min), but in NTAL / 
cells it exhibited a slower decline at later stages of activation
(15 and 25 min).
NTAL Negatively Regulates the PI3K Activity. Early bio-
chemical events in Fc RI-activated mast cells are depen-
dent on the activity of PI3K, which functionally interacts
with Gab2 and several other signaling proteins (26, 27).
Therefore, we monitored the subcellular distribution and
enzymatic activity of PI3K in WT and NTAL /  BMMCs.
PI3K was immunoprecipitated from saponin/Triton X-100–
solubilized cells, and its amount was quantified by immu-
Figure 4. Tyrosine phosphorylation of Fc RI, Syk, LAT, and ERK.
BMMCs from WT and NTAL /  cells were sensitized with anti-TNP
IgE and stimulated with TNP-BSA (100 ng/ml) for the indicated time
intervals. The cells were solubilized in lysis buffer containing 0.2% Triton
X-100 (A), 1% NP-40, and 1% n-dodecyl- -d-maltoside (C and D) or
by sequential treatment with 0.1% saponin and 1% Triton X-100 (B).
Fc RI (A), Syk (B), and LAT (C) were immunoprecipitated (IP) from
postnuclear supernatants with the corresponding antibodies. The immuno-
precipitates were resolved by SDS-PAGE and analyzed by immunoblotting
using PY-20–HRP conjugate (top). After stripping, the same membranes
were reblotted with protein-specific antibodies (bottom). Phosphorylated
ERK (pERK) and ERK were determined by immunoblotting in size-frac-
tionated whole cell lysates using anti-pERK antibody, followed by strip-
ping and immunoblotting with ERK-specific antibody (D). Fold induc-
tions of protein tyrosine phosphorylation, normalized to nonactivated
WT cells and corrected for the amount of the protein in each immuno-
precipitate, are also indicated. A typical result from two to four experi-
ments performed is presented.
Figure 5. PI3K, SHP-2, and Grb2 immunocomplexes. BMMCs from
WT and NTAL /  mice were activated with TNP-BSA (100 ng/ml) for
the indicated time intervals, solubilized with saponin/Triton X-100, and
PI3K, SHP-2, and Grb2 immunocomplexes were isolated by immuno-
precipitation with the corresponding antibodies. (A) PI3K immunopre-
cipitates were analyzed for (a) PI3K activity (PI3K a.) using PI as a sub-
strate and TLC (position of [32P]PI [PIP] is indicated by arrow) and (b)
the amount of immunoprecipitated PI3K by immunoblotting with anti–
PI3K-p85. (B) SHP-2 immunoprecipitates were analyzed for (a) SHP-2–
associated PI3K activity by PI3K assay, (b) the amount of SHP-2 by immu-
noblotting with anti–SHP-2 antibody, and (c) SHP-2 enzymatic activity by
in-gel phosphatase assay (SHP-2 a.). (C) Grb2 immunoprecipitates were
analyzed by immunoblotting for the presence of tyrosine-phosphorylated
proteins, NTAL and Grb2. Relative amounts of the immunoprecipitated
proteins, their tyrosine phosphorylations, and/or enzymatic activities
were normalized to nonactivated WT cells. Representative data from
two to four experiments performed are shown.Volná et al. 1007
noblotting. Enzymatic activity of PI3K in the immune
complexes was determined using PI as a substrate, and the
expected product [32P]PI (PIP) was detected by autora-
diography. Similar to a previous study performed with
RBL-2H3 cells (23), we observed an activation-induced
increase in recovery of PI3K from saponin-permeabilized
WT BMMCs (Fig. 5 A), consistent with translocation of
PI3K to the plasma membrane. The changes in the distri-
bution of PI3K were accompanied by an enhanced PI3K
enzymatic activity with peak at 2 min after Fc RI trigger-
ing. In nonactivated NTAL /  cells, the enzymatic activity
of PI3K was slightly lower than in WT cells. However, 0.5
min after Fc RI triggering the PI3K activity was 2.5-fold
higher in NTAL /  and remained higher at all time inter-
vals analyzed.
One of the proteins interacting with PI3K is the ubiqui-
tously expressed nonreceptor tyrosine phosphatase SHP-2
(28). Because SHP-2 regulates PI3K activity (29), we fur-
ther compared the SHP-2–associated PI3K activity in WT
and NTAL /  cells. SHP-2 was immunoprecipitated from
saponin/Triton X-100–solubilized cells, and the enzymatic
activity of SHP-2–coprecipitated PI3K was determined.
Data presented in Fig. 5 B show that PI3K enzymatic activ-
ity was elevated after Fc RI triggering in both WT and
NTAL /  cells but was more rapidly down-regulated in
NTAL /  cells at later time intervals (5 min). Total enzy-
matic activity of SHP-2 phosphatase, as detected by in-gel
assay, was higher in nonactivated NTAL /  than in WT
cells (2.8   0.3-fold increase, n   3) and remained higher
after Fc RI triggering at all time intervals analyzed.
NTAL Is a Major Tyrosine Phosphorylated Target of Grb2.
5 of the total 10 consensus tyrosine phosphorylation sites in
NTAL, and in LAT, are of the YXN type (where X is any
amino acid), and are thus potential binding sites for the
SH2 domain of the cytoplasmic adaptor Grb2. Anti-NTAL
immunoblotting of Grb2 immunoprecipitates showed an
enhanced association of NTAL and Grb2 after Fc RI en-
gagement in WT BMMCs (Fig. 5 C). Among the tyrosine-
phosphorylated proteins in activated WT cells, NTAL was
a major Grb2 target, as determined by PY-20 immunoblot-
ting. Interestingly, more tyrosine-phosphorylated protein
of 38 kD, presumably LAT, was bound to Grb2 in
NTAL /  cells compared with WT cells.
Enhanced PLC  Activity and Calcium Response in NTAL / 
BMMCs. The observed increase in tyrosine phosphoryla-
tion of LAT implied elevated levels of PLC  activity in
NTAL /  cells, and we therefore evaluated the properties
of immunoisolated PLC . Data presented in Fig. 6 A indi-
cate that tyrosine phosphorylation of PLC 1 was indeed
enhanced; 2 and 5 min after Ag triggering the enhance-
ment was, respectively, 4.8- and 4-fold higher in NTAL / 
cells than in WT cells. Tyrosine phosphorylation of PLC 2
isolated from NTAL /  cells was also enhanced (Fig. 6 B).
Next, we analyzed the PLC  enzymatic activity. PLC 2
was immunoprecipitated, and its enzymatic activity, result-
ing in the production of [3H]IP3 from P[3H]IP2 substrate,
was determined. As shown in Fig. 6 C, PLC  activity in
Fc RI-activated cells was significantly higher in NTAL / 
cells than in WT cells. The enhanced PLC  activity in
NTAL /  cells resulted in higher accumulation of IP3, the
critical PLC  metabolite (Fig. 6 D).
Since an enhanced activity of PLC  and production of
IP3 are prerequisites for Fc RI-mediated calcium responses,
we also estimated the [Ca2 ]i in WT and NTAL /  cells.
After an exposure of IgE-sensitized and Fura-2–loaded cells
to low concentrations of Ag (5 or 10 ng/ml) in the pres-
ence of extracellular Ca2 , only a small increase in [Ca2 ]i
was observed in WT cells, whereas the response was mark-
edly enhanced in NTAL /  cells (Fig. 7, A and B). At a
higher concentration of Ag (100 ng/ml), the difference be-
tween WT and NTAL /  cells was less dramatic, due to
enhanced calcium response in WT cells but remained sig-
nificant (Fig. 7 C). An elevated calcium response was also
observed in NTAL /  cells activated in the absence of ex-
tracellular Ca2  (Fig. 7 D).
Fc RI-mediated increase in [Ca2 ]i in the presence of
extracellular Ca2  reflects not only a transient release of in-
Figure 6. Tyrosine phosphorylation and enzymatic activity of PLC .
BMMCs from WT and NTAL /  mice were activated for the indicated
time intervals with TNP-BSA (100 ng/ml). (A and B) The cells were sol-
ubilized with saponin/Triton X-100, and PLC 1 (A) and PLC 2 (B)
were immunoprecipitated and analyzed by immunoblotting using phos-
photyrosine-specific PY-20–HRP conjugate (top). Subsequently, after
stripping the same membranes were reblotted with anti-PLC 1 (A) and
anti-PLC 2 (B) (bottom). Representative data from two experiments
performed are shown. (C) The cells were lysed in 1% Triton X-100, and
enzymatic activity of the immunoprecipitated PLC 2 was measured by
immune complex PLC  assay; the data were normalized to nonactivated
WT cells. (D) IP3 levels were determined by 3H-radioreceptor assay kit as
described in Materials and Methods. Data in C and D represent means  
SD (n   3–4).NTAL in Mast Cell Signaling 1008
tracellularly stored Ca2  but also a more sustained influx of
Ca2  from the extracellular medium through incompletely
characterized store-operated channels in the plasma mem-
brane (30). To determine whether NTAL has any effect on
the influx of extracellular Ca2 , we measured the uptake of
45Ca from the extracellular medium. In nonactivated cells,
the uptake of 45Ca was low and there was no difference be-
tween WT and NTAL /  cells. When the cells were ex-
posed to increasing concentrations of TNP-BSA, the 45Ca
uptake rose in WT cells and even more so in NTAL / 
cells. The enhancement of 45Ca uptake in NTAL /  cells
was observed at all concentrations of Ag used (up to 1  g/
ml; Fig. 7 E) and at all time intervals analyzed (up to 15
min; Fig. 7 F).
Impaired Secretory and Calcium Responses in NTAL / /
LAT /  BMMCs. Although LAT and NTAL are struc-
turally similar adaptor molecules, their absence has dramat-
ically different consequences on Fc RI-mediated events in
BMMCs. In LAT /  cells, the secretory and Ca2  re-
sponses are partially inhibited (7), whereas in NTAL /  the
same responses are potentiated (see Figs. 3–7). To deter-
mine the properties of cells defective simultaneously in both
these adaptor proteins, we prepared NTAL / /LAT / 
mice and examined their BMMCs. When the cells were
solubilized and analyzed by immunoblotting, no proteins
reactive with anti-NTAL– and anti-LAT–specific Abs
were detected (not depicted). The NTAL / /LAT / 
BMMCs differed from the cells expressing both adaptor
proteins neither in their growth properties nor in their ex-
pression of surface Fc RI. Data presented in Fig. 3 B indi-
cate that NTAL / /LAT /  cells exhibited lower secre-
tory response than LAT /  cells. Similarly, calcium response
in NTAL / /LAT /  cells was lower than in LAT /  cells
(Fig. 7 C). It should be noted that although they were dra-
matically reduced, the secretory and calcium responses
were not completely inhibited. Furthermore, there was no
significant difference in degranulation and calcium re-
sponses induced by the ionophore A23187 in WT, LAT / ,
and NTAL / /LAT /  BMMCs (not depicted), demon-
strating that degranulation itself does not depend on the
presence of these linker proteins.
Different Membrane Topography of NTAL and LAT in Rest-
ing and Activated Cells. Both NTAL and LAT partition
into lipid rafts, as can be inferred from their detergent resis-
tance and association with buoyant density fractions of su-
crose gradient (2). However, a direct comparison of the
distribution of these two adaptors in sucrose gradients has
not been reported. Data presented in Fig. 8 indicate that in
WT cells both LAT and NTAL are located predominantly
in low density fractions of sucrose gradient (fractions 1–4).
In Ag-activated cells, the amount of LAT in these fractions
was decreased, and tyrosine-phosphorylated LAT was found
Figure 7. Ca2  mobilization and extracellular 45Ca uptake. (A–D) IgE-
sensitized BMMCs were loaded with Fura-2-AM and stimulated with
various concentrations of TNP-BSA (5 ng/ml [A], 10 ng/ml [B], or 100
ng/ml [C and D]) added at the time point indicated by arrows, in the
presence (A–C) or absence (D) of 1.0 mM extracellular Ca2 . The Ca2 
mobilization was monitored by spectrofluorometry in WT and NTAL / 
(A–D) and at a single concentration of TNP-BSA (100 ng/ml) also in
LAT /  and NTAL / /LAT /  (C) BMMCs. Representative data from
at least three to five experiments are shown. (E and F) Uptake of calcium
from extracellular medium was measured in IgE-sensitized WT and
NTAL /  cells activated in the presence of extracellular 45Ca2  (1 mM)
for 5 min with various concentrations of TNP-BSA (E) or activated with
100 ng/ml of TNP-BSA for various time intervals (F). Data in E and F
represent means   SD (n   3–6).
Figure 8. Distribution of NTAL and LAT in sucrose gradients. BMMCs
from WT or NTAL /  mice were sensitized with TNP-specific IgE and
activated or not with TNP-BSA (100 ng/ml) for 5 min. The cells were
solubilized in a lysis buffer containing 1% Brij 96, and the whole cell lysates
were fractionated by sucrose density gradient ultracentrifugation. Individual
fractions were collected and analyzed by immunoblotting for the presence of
NTAL and LAT and their phosphorylated forms (PY-20). Percentage of
NTAL and LAT and their phosphorylated forms in low density fractions
(fraction 1–4) is indicated by numbers under fractions.Volná et al. 1009
predominantly in high density fractions. Although the amount
of NTAL in low density fractions also decreased in acti-
vated cells (from 74.3 to 47.8%), most of the tyrosine-
phosphorylated NTAL was found in lipid rafts fractions
(69.5%). Compared with WT cells, NTAL /  cells exhib-
ited higher amount of LAT in low density fractions in both
nonactivated and activated cells. This difference was even
more pronounced when the distribution of tyrosine-phos-
phorylated LAT was analyzed (38.9 versus 66.6%). These
data suggested that at least a fraction of LAT and NTAL
could associate with different lipid-containing structures in
plasma membrane.
To throw more light on the topography of LAT and
NTAL, we isolated membrane sheets from an adherent
mast cell line, RBL-2H3, which also possesses the two
adaptor proteins (unpublished data), and analyzed their to-
pography by immunogold electron microscopy. In resting
cells, both NTAL and LAT were found in small clusters
that distributed independently of Fc RI   subunits (Fig. 9,
A and C). Based on the Hopkins test, these clusters were
significantly different from random patterns. After Fc RI
aggregation, the Fc RI   subunits accumulated predomi-
nantly in osmiophilic regions of the plasma membrane, thus
confirming previously published data (24, 31). Clusters of
both NTAL and LAT were often found in the vicinity of
aggregated Fc RI, without forming mixed aggregates with
them (Fig. 9, B and D).
Finally, we attempted to find out whether NTAL and
LAT form mixed aggregates before and/or after Fc RI ag-
gregation. To this end, we double labeled membrane sheets
for LAT and NTAL, using combinations of 5- and 10-nm
gold particles (Fig. 10). The labeling with 5-nm gold parti-
cles was consistently more abundant, regardless of whether
the target was LAT or NTAL. This difference reflects tech-
nical aspects of the assay, since smaller gold particles more
efficiently label target molecules than large gold particles.
In nonactivated cells, LAT and NTAL each formed small
clusters which did not mix. The visual observations that
LAT and NTAL fail to mix were confirmed using the Rip-
ley’s statistical test (not depicted). Importantly, clusters of
these transmembrane adaptors can often be seen in or near
osmiophilic patches of activated membranes, but again no
mixing of NTAL and LAT molecules was observed. Thus,
NTAL and LAT are located in distinct, nonoverlapping re-
gions of the plasma membrane in both nonactivated and
activated cells.
Figure 9. Membrane topogra-
phy of NTAL, LAT, and Fc RI
  subunit in nonactivated and
Ag-activated cells. Membrane
sheets were prepared from IgE-
sensitized RBL-2H3 cells exposed
for 2 min to PBS alone (A and C)
or DNP-BSA in PBS (1  g/ml;
B and D), and double labeled
from the cytoplasmic side of the
plasma membrane for Fc RI   
subunit (10-nm gold particles,
arrows;  A–D), NTAL (5-nm
gold particles, arrowheads; A and
B), or LAT (5-nm gold particles,
arrowheads; C and D).NTAL in Mast Cell Signaling 1010
Discussion
The structural similarity of NTAL and LAT suggested
that those two proteins could have similar functions. This
notion was supported by their expression pattern. Whereas
NTAL is expressed in B cells, which lack LAT, the reverse
is true for LAT. Studies with LAT-deficient mice revealed
a complete block in T cell development (17, 32), and LAT-
negative T cell lines showed a complete block in TCR sig-
naling (33, 34). Importantly, transfection of NTAL into
LAT-deficient cells or mice partially restored the defects (2,
3, 5). Mast cells express both these proteins, and LAT defi-
ciency had no effect either on mast cell development in
vivo or maturation of mast cells in vitro (7). However,
BMMCs from LAT /  mice exhibited defects in pathways
known to be downstream of Lyn and Syk kinase activation.
These included Fc RI-mediated tyrosine phosphorylation
of PLC , production of IP3, release of Ca2  from internal
stores, and degranulation. Importantly, though the mast cell
effector functions were impaired, they were not completely
inhibited (7). These data together with enhanced tyrosine
phosphorylation of NTAL in Fc RI-activated mast cells (2)
and normal development of NTAL /  mast cells under in
vivo and in vitro conditions (this study) suggested that
NTAL could be the missing adaptor protein responsible for
the remaining signaling activity noted in LAT-deficient
cells. However, several lines of evidence presented in this
study indicate that NTAL, unlike LAT, has a negative reg-
ulatory role in Fc RI-mediated activation in mouse mast
cells. First, NTAL /  mice compared with WT mice ex-
hibited an enhanced passive anaphylactic response. This sys-
temic reaction reflects the activity of mast cells and was
found reduced in LAT /  cells (7). Second, BMMCs from
NTAL /  mice exhibited an enhanced degranulation. Third,
several proteins in Fc RI-activated NTAL /  cells exhib-
ited an enhanced tyrosine phosphorylation and/or modified
subcellular distribution. These proteins included Syk kinase,
LAT, ERK, and PLC . Fourth, Fc RI-activated NTAL / 
cells exhibited an enhanced activity of PLC  and PI3K,
producing increased levels of IP3 and PI 3,4,5-trisphos-
phate, respectively. Finally, NTAL /  phenotype was asso-
ciated with a dramatic increase in calcium response in Ag-
activated cells. This enhancement was mostly pronounced
at suboptimal concentrations of the Ag and was observed
even in the absence of extracellular calcium, suggesting that
the enhanced release of calcium from intracellular stores
contributes at least in part to this phenomenon. Thus, the
conclusion based on our data seems to indicate that Fc RI-
Figure 10. Different localiza-
tion of NTAL and LAT clusters.
Membrane sheets were prepared
from nonactivated (A and C) and
DNP-BSA–activated (1  g/ml;
B and D) RBL-2H3 cells and
double-labeled from the inside
for LAT (arrows), marked with
10-nm (A and B) or 5-nm (C
and D) gold particles, and NTAL
(arrowheads) marked with 5-nm
(A and B) or 10-nm (C and D)
gold particles.Volná et al. 1011
mediated signaling events in BMMCs are negatively regu-
lated by NTAL.
How could NTAL be involved in negative regulation of
PLC  and downstream signaling pathways? We propose
that the inhibitory role of NTAL could result from its
competition with LAT in lipid rafts. Furthermore, it should
be noted that a major difference between LAT and NTAL
is in the absence of the tyrosine residue responsible for in-
teraction with PLC  in the latter. In the absence of
NTAL, more LAT is located in lipid rafts (Fig. 8) and is ty-
rosine phosphorylated (Fig. 4 C), resulting in (a) an in-
creased recruitment of PLC  into complexes formed
around aggregated Fc RI, (b) enhanced tyrosine phos-
phorylation and enzymatic activities of PLC , (c) elevated
production of IP3 and [Ca2 ]i, and (d) more potent de-
granulation. Alternatively, NTAL could have a negative
regulatory role in Fc RI signaling by indirect binding of
phosphatases. In T cells, TCR ligation induces binding of
Grb2 with SHP-2, and this interaction presumably brings
the phosphatase into juxtaposition to its potential substrates
(35). In stimulated mast cells, phosphorylated NTAL is a
major binder of Grb2 (Fig. 5 C), and therefore, it is possi-
ble that in the absence of NTAL Grb2–phosphatase com-
plexes are not properly targeted, and down-regulating sig-
naling pathways are less effective. It should be mentioned
that these two hypotheses are not mutually exclusive: in
the absence of NTAL, more tyrosine-phosphorylated LAT
in lipid rafts (Fig. 8) could better serve as a substrate for sig-
naling molecules, and at the same time the signaling mole-
cules could be more active due to the absence on NTAL-
bound protein tyrosine phosphatases.
Our experiments with BMMCs defective in both adaptor
proteins, NTAL and LAT, surprisingly reveal that NTAL,
besides its negative regulatory role, may potentially also
have a positive role in Fc RI signaling. Clearly, NTAL in
the absence of LAT cannot play the above described inhibi-
tory (competitive) role and it may take over, albeit with
lower efficiency, some of the functions of LAT, just as it
was observed in T cells (2, 3, 5). Which of these two func-
tions would prevail could possibly depend on qualitative
and/or quantitative differences in the composition of the
signaling assemblies induced by Fc RI aggregation. These
differences could explain why a diminution of NTAL ex-
pression by silencing RNA oligonucleotides in human mast
cells resulted in an opposite phenotype (reduction of Fc RI-
mediated secretory and calcium responses [6]) compared
with that observed in NTAL /  BMMCs (this study). In
this context, it should be noted that profiles of tyrosine-
phosphorylated proteins in human and mouse mast cells are
very different (6). Furthermore, the influence of different
tissue origins and cell culture conditions used for growth of
human and mouse mast cells could also play a role.
Mast cell degranulation involves two signaling pathways
proximal to Fc RI. Lyn-dependent pathway, which in-
volves transmembrane adaptor LAT, serves as both kinetic
accelerator and negative regulator of signaling, whereas Fyn-
dependent pathway is essential for degranulation (8). Experi-
ments with human mast cells suggested that NTAL could
represent the transmembrane adaptor involved in the Fyn-
dependent pathway (6). However, our findings that NTAL
in mouse BMMCs is not essential for degranulation (Fig. 3)
and that tyrosine phosphorylation of NTAL is not depen-
dent on Fyn kinase activity but at least partially depends on
Lyn kinase activity (unpublished data) suggest that NTAL is
not involved in the Fyn-dependent pathway. Rather, NTAL
could contribute in part to the complexity of Lyn-dependent
regulatory mechanisms of mast cell signaling.
Although both NTAL and LAT are structurally similar
molecules partitioning into lipid rafts in detergent-solubi-
lized cells, a detailed analysis of their distribution on sucrose
gradients indicate that they differ in physical properties,
particularly in activated cells. Thus,  60% of tyrosine-
phosphorylated LAT was found in high density fractions of
sucrose gradient, whereas a larger fraction ( 70%) of phos-
phorylated NTAL was found in low density fractions (Fig.
8). These data suggest that the two molecules do not oc-
cupy the same regions of the plasma membrane. This was
confirmed by electron microscopy analysis on membrane
sheets. Previously, it has been shown that LAT in resting
cells is found in clusters which do not mix with dispersed
clusters of Fc RI   subunits (24, 31). We have confirmed
these results and demonstrated that NTAL was also found
in clusters that were similar in size to LAT clusters. Inter-
estingly, NTAL clusters were topographically separated
from LAT clusters. Aggregation of Fc RI induced a redis-
tribution of the receptor into distinct areas of the plasma
membrane that are characterized by their dark staining with
osmium, proximity of clathrin-coated pits, and accumula-
tion of several signaling molecules (24, 31). Although
NTAL and LAT were often found in the vicinity of these
aggregates, they did not form mixed aggregates.
In conclusion, our data indicate that at least in murine
mast cells, NTAL mostly negatively regulates the activation
through Fc RI. Therefore, it can be speculated that the ab-
sence, reduced expression, or mutations in this adaptor
protein might be a contributing factor in an increased sen-
sitivity to allergens.
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